Atlas Trials

Residual Neuromuscular Block (TOF-ratio of 0.2)

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Residual Neuromuscular Block (TOF-ratio of 0.2)

RecordFirmDate
Sugammadex and Neostigmine at Residual Neuromuscular Blockade (NCT01006720)Technical University of Munich2009-03-01

Track Residual Neuromuscular Block (TOF-ratio of 0.2) automatically

Every clearance here is in the API, with alerts when new ones post.